Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

Completed

Conditions studied: Atrial Fibrillation

In brief

ELITE (Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients) is a two year research project to assess warfarin management issues faced by atrial fibrillation (AF) patients in ambulatory settings.

Key facts

Study ID

NCT02461602

Run by

Duke University

People needed

251

Starts

2016-02-01

Expected to finish

2018-05-31

Last updated by the study team

2019-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older at the time of enrollment
• Electrocardiographically confirmed AF
• Able to complete patient-reported outcomes surveys
• Initiated warfarin therapy in the prior 3 months
• Ability to adhere to regular clinical visits
• Ability to sign informed consent
• Ability to read/comprehend/speak English

You may not qualify if…

• Anticipated life expectancy less than six months (as determined by the site investigator)
• Transient AF secondary to a reversible condition (hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery)
• Recent Deep Venous Thrombosis(DVT) or Pulmonary Embolism (PE) (within 6 months)
• Participation in a randomized trial of anticoagulation for AF
• Use of a home international normalized ratio (INR) monitoring system

Where it is running

• Foothill Cardiology — Pasadena, California, United States
• Holy Cross Medical Group — Coral Springs, Florida, United States
• Charlotte Heart Group — Port Charlotte, Florida, United States
• Atlanta Institute for Medical Research, Inc. — Atlanta, Georgia, United States
• Atlanta Heart Specialists — Cumming, Georgia, United States
• Cardiovascular Research of Northwest Indiana, L.L.C. — Munster, Indiana, United States
• Research Integrity, LLC. — Owensboro, Kentucky, United States
• Ochsner Health System — New Orleans, Louisiana, United States
• Penobscot Bay Medical Center — Rockport, Maine, United States
• Endeavor Medical Research — Alpena, Michigan, United States
• Great Lakes Heart and Vascular Institute — Saint Joseph, Michigan, United States
• HealthEast Medical Research Institute — Saint Paul, Minnesota, United States
• Jackson Heart Clinic — Jackson, Mississippi, United States
• Cardiovascular Associates of the Delaware Valley — Elmer, New Jersey, United States
• Lourdes Cardiology Services — Voorhees Township, New Jersey, United States
• Duke Cardiology of Lumberton — Lumberton, North Carolina, United States
• Doylestown Health Cardiology — Doylestown, Pennsylvania, United States
• Columbia Heart Clinic, PA — Columbia, South Carolina, United States
• North Texas Research Associates — Allen, Texas, United States
• Providence Health Center — Waco, Texas, United States
• Riverside Cardiology Specialists — Newport News, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.